This document discusses canaloplasty, a new minimally invasive glaucoma treatment. It provides background on glaucoma, risk factors for the disease, and current treatment options like laser surgeries, trabeculectomy, and drainage devices. The document then focuses on canaloplasty, describing it as a non-penetrating procedure that uses a flexible microcatheter to pass through the eye's drainage canal 360 degrees. It notes the benefits of canaloplasty include lower intraocular pressure and fewer medication requirements compared to traditional surgeries, with a safer profile and no complications. A quote from the inventor of canaloplasty praises it as the closest procedure to having no complications.
Dr. David Donelson, medical director of Donelson Eye Associates, treats a variety of vision-related conditions, including cataracts and myopia as well as treating patients with diabetic retinopathy and age-related macular degeneration.
What's New In Glaucoma Surgery [OD CE 2 credit hours] - PPT Slides and VideosDr David Richardson
What's New In Glaucoma Surgery Presentation. A Continuing Education course for Optometrists presented by Patient-Focused Ophthalmologist, Dr. David Richardson.
At the end of the presentation audience participants became familiar with the main benefits and risks of currently available glaucoma treatments as well as had awareness of the most promising potential future surgical glaucoma treatments.
This OD CE Course was held at Green Street Tavern, Pasadena, CA last May 20, 2015.
=========================
[Glaucoma Surgeon, California] Dr. David Richardson is a board certified Ophthalmologist and Eye Surgeon in California specializing in the treatment of Cataract and Glaucoma. He is the Medical Director of San Marino Eye (Vision Center), located in San Marino, California. He’s the former Chief of Surgery and now Vice Chief of Staff at San Gabriel Valley Medical Center. Dr. Richardson has performed thousands of advanced cataract and Canaloplasty glaucoma procedures with excellent results.
More information about Dr. Richardson: http://David-Richardson-MD.com
New Glaucoma Treatments is a GLAUCOMA HealthHub maintained by David Richardson, M.D. It’s primary purpose is to provide valuable information to glaucoma patients and their caregivers worldwide about the latest developments and treatments for glaucoma, while providing answers to commonly asked questions about glaucoma, care and treatment options.
More information about new glaucoma treatments here: http://new-glaucoma-treatments.com
“Adjusting the Faucet or Opening the Drain – Currently Available Methods to Treat the Plumbing Problem of Open Angle Glaucoma”
A San Gabriel Valley Optometric Society (SGVOS) Continuing Education Dinner Event – 2 hours CE | Featured Speaker: Dr. David Richardson, MD | April 12, 2017
Learn more about Dr. David Richardson: http://David-Richardson-MD.com
Glaucoma is a lifestyle disease. Its treatment via traditional surgery (ie. trabeculectomy) or via glaucoma medications, negatively impacts the lifestyle of patients. In this presentation, Dr. David Richardson presents the new, non-invasive glaucoma treatment, Canaloplasty. Canaloplasty is a lifestyle surgery for Glaucoma.
INTERVENTIONAL GLAUCOMA: SLT AND MIGS
A Roundtable Discussion Of Nondestructive Interventional Treatments For Open-angle Glaucoma
Cataract & Refractive Surgery Today
SUPPLEMENT | AUGUST 2018
Sponsored by Ellex Medical
Source: https://crstoday.com/articles/2018-aug/interventional-glaucoma-slt-and-migs/
-----
Iqbal Ike K. Ahmed, MD, FRCSC, introduces this roundtable discussion of different paradigms in glaucoma therapy, with Mahmoud A. Khaimi, MD; Mark J. Gallardo, MD; David Richardson, MD; Nathan M. Radcliffe, MD; and I. Paul Singh, MD. The surgeons share their current treatment strategies for open-angle glaucoma and discuss how to incorporate selective laser trabeculoplasty and minimally invasive glaucoma surgery (MIGS) into practice.
-----
At ASCRS 2018 in Washington, DC, a group of surgeons experienced in interventional glaucoma therapies sat down to discuss the roles of selective laser trabeculoplasty (SLT) and microinvasive glaucoma surgery (MIGS) for treatment of openangle glaucoma (OAG).
The term interventional glaucoma refers to more than simply technology. It is a mindset that the available technologies bring to us as surgeons and clinicians. Instead of being passive and watchful, waiting for our patients to progress, interventional glaucoma allows us to be actively involved in their care by providing interventional therapies that change the course of the disease. I am very excited about interventional glaucoma and how it shapes the future of glaucoma care.
In this roundtable, we will discuss a number of technologies used in the interventional glaucoma model. First, we want to hear about SLT and its relevance in glaucoma therapy today, including the interplay of SLT and MIGS options. We also will talk about our experiences with ab interno canaloplasty (ABiC) performed with the iTrack surgical system (Ellex), its role in rejuvenating the natural outflow system, and its place among MIGS procedures.
—Iqbal “Ike” K. Ahmed, MD, FRCSC, Moderator
Dr. David Donelson, medical director of Donelson Eye Associates, treats a variety of vision-related conditions, including cataracts and myopia as well as treating patients with diabetic retinopathy and age-related macular degeneration.
What's New In Glaucoma Surgery [OD CE 2 credit hours] - PPT Slides and VideosDr David Richardson
What's New In Glaucoma Surgery Presentation. A Continuing Education course for Optometrists presented by Patient-Focused Ophthalmologist, Dr. David Richardson.
At the end of the presentation audience participants became familiar with the main benefits and risks of currently available glaucoma treatments as well as had awareness of the most promising potential future surgical glaucoma treatments.
This OD CE Course was held at Green Street Tavern, Pasadena, CA last May 20, 2015.
=========================
[Glaucoma Surgeon, California] Dr. David Richardson is a board certified Ophthalmologist and Eye Surgeon in California specializing in the treatment of Cataract and Glaucoma. He is the Medical Director of San Marino Eye (Vision Center), located in San Marino, California. He’s the former Chief of Surgery and now Vice Chief of Staff at San Gabriel Valley Medical Center. Dr. Richardson has performed thousands of advanced cataract and Canaloplasty glaucoma procedures with excellent results.
More information about Dr. Richardson: http://David-Richardson-MD.com
New Glaucoma Treatments is a GLAUCOMA HealthHub maintained by David Richardson, M.D. It’s primary purpose is to provide valuable information to glaucoma patients and their caregivers worldwide about the latest developments and treatments for glaucoma, while providing answers to commonly asked questions about glaucoma, care and treatment options.
More information about new glaucoma treatments here: http://new-glaucoma-treatments.com
“Adjusting the Faucet or Opening the Drain – Currently Available Methods to Treat the Plumbing Problem of Open Angle Glaucoma”
A San Gabriel Valley Optometric Society (SGVOS) Continuing Education Dinner Event – 2 hours CE | Featured Speaker: Dr. David Richardson, MD | April 12, 2017
Learn more about Dr. David Richardson: http://David-Richardson-MD.com
Glaucoma is a lifestyle disease. Its treatment via traditional surgery (ie. trabeculectomy) or via glaucoma medications, negatively impacts the lifestyle of patients. In this presentation, Dr. David Richardson presents the new, non-invasive glaucoma treatment, Canaloplasty. Canaloplasty is a lifestyle surgery for Glaucoma.
INTERVENTIONAL GLAUCOMA: SLT AND MIGS
A Roundtable Discussion Of Nondestructive Interventional Treatments For Open-angle Glaucoma
Cataract & Refractive Surgery Today
SUPPLEMENT | AUGUST 2018
Sponsored by Ellex Medical
Source: https://crstoday.com/articles/2018-aug/interventional-glaucoma-slt-and-migs/
-----
Iqbal Ike K. Ahmed, MD, FRCSC, introduces this roundtable discussion of different paradigms in glaucoma therapy, with Mahmoud A. Khaimi, MD; Mark J. Gallardo, MD; David Richardson, MD; Nathan M. Radcliffe, MD; and I. Paul Singh, MD. The surgeons share their current treatment strategies for open-angle glaucoma and discuss how to incorporate selective laser trabeculoplasty and minimally invasive glaucoma surgery (MIGS) into practice.
-----
At ASCRS 2018 in Washington, DC, a group of surgeons experienced in interventional glaucoma therapies sat down to discuss the roles of selective laser trabeculoplasty (SLT) and microinvasive glaucoma surgery (MIGS) for treatment of openangle glaucoma (OAG).
The term interventional glaucoma refers to more than simply technology. It is a mindset that the available technologies bring to us as surgeons and clinicians. Instead of being passive and watchful, waiting for our patients to progress, interventional glaucoma allows us to be actively involved in their care by providing interventional therapies that change the course of the disease. I am very excited about interventional glaucoma and how it shapes the future of glaucoma care.
In this roundtable, we will discuss a number of technologies used in the interventional glaucoma model. First, we want to hear about SLT and its relevance in glaucoma therapy today, including the interplay of SLT and MIGS options. We also will talk about our experiences with ab interno canaloplasty (ABiC) performed with the iTrack surgical system (Ellex), its role in rejuvenating the natural outflow system, and its place among MIGS procedures.
—Iqbal “Ike” K. Ahmed, MD, FRCSC, Moderator
Cataract Surgery pros and cons - FOCUS Eye Centre SydneySurgical Partners
FOCUS Eye Centre Ophthalmologist and Director Dr Richard Smith presentation: CATARACT SURGERY Pro’s and Con’s - Phaco vs Femto, Monofocal vs Multifocal IOLs
This presentation describes indications of intrastromal corneal rings implantation in keratoconus cases and how they are beneficial even in advanced cases.
Cataract Surgery pros and cons - FOCUS Eye Centre SydneySurgical Partners
FOCUS Eye Centre Ophthalmologist and Director Dr Richard Smith presentation: CATARACT SURGERY Pro’s and Con’s - Phaco vs Femto, Monofocal vs Multifocal IOLs
This presentation describes indications of intrastromal corneal rings implantation in keratoconus cases and how they are beneficial even in advanced cases.
To view recording of the webinar please use the below URL:
http://wso2.com/library/webinars/2015/05/paas-for-the-new-cloud-era/
n this session, Asanka Abeysinghe, VP of solutions architecture at WSO2, will explain how WSO2 Cloud technologies can leverage to meet business and technical demand. He will also explain how to define a programming model, build cloud-native applications, and increase developer productivity by providing foundation services hosted by PaaS. This session will use vendor neutral reference architecture patterns and use WSO2 Private PaaS as a platform to explain implementation details.
CSI Insieme N°25 – Titoli: CSI: in tempo di crisi speranza per l’Italia - All’assalto del castello di Breno 230 atleti under 14 del CSI - Il tennistavolo si prepara al Gran premio nazionale - A Cimbergo Cotti Cottini e Antonini coppia sovrana
Communication networks are the vital part of today’s world and based mostly on the optical networks. Nestor Cables provides all needed passive components to the optical network and we are privileged to develop this vital sector in forefront providing our customers continuously developing product portfolio. Additionally we also provide copper telecommunication cables for all applications and industrial copper cables for automation and control purposes. Industries we serve: Energy, Oil&Gas, Utilities, Telecommunications, Security, Defence, etc.
Presentación Cliente Final - WSI drivebiz - Consultoria en marketing InternetRicardo Delgado
Me han sugerido que escriba una breve presentación acerca del significado de "arquitectura de conversión" de una Web site, de "optimización SEO" en motores de búsquedas y "redes sociales" ; mostrando su importancia en los procesos de venta de una empresa. Tras corregir y traducir recursos WSI, le he dado un hilo conductor aceptable y espero dar en el clavo; recordemos: "drivebiz" es parte del gran mundo de especialistas en marketing online WSI (87 países). Confíenos su próximo proyecto de Internet.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
26. “It is vital to find a safer, more predictable operation
with preferably no complications at all. This is the
closest I have ever come to that.”
~ Robert C. Stegmann, M.D.
Father of Canaloplasty
Chairman, Medical University of Southern Africa
It is common…
Estimated Number of Glaucoma Cases in the United States, Age ≥ 40: 2,719,379
Source: Prevent Blindness America | http://www.visionproblemsus.org/
It is common…
Estimated Number of Glaucoma Cases in the United States, Age ≥ 40: 2,719,379
Source: Prevent Blindness America | http://www.visionproblemsus.org/
Normal vs. cupped out image of the Optic Nerve
What Is Glaucoma?
Glaucoma is a common disease of the eye which results from the dysfunction in the eye’s drainage system that leads to irreversible blindness. Clogging of this drainage system eventually results in an increase in intraocular pressure (IOP) which damages the eye’s delicate structures, especially the nerve responsible for vision (optic nerve).Read more: http://david-richardson-md.com/glaucoma-treatments/guidelines/#ixzz3IZlehHpo
Why You Should Care?
It is common…
Estimated Number of Glaucoma Cases in the United States, Age ≥ 40: 2,719,379
Source: Prevent Blindness America | http://www.visionproblemsus.org/
…but only half of those know they have it.
It’s silent
Glaucoma is often called “the sneak thief of sight.” That’s because people usually do
not notice any signs of the disease until they have already lost significant vision.
It’s blinding
In the U.S., more than 120,000 are blind from glaucoma, accounting for 9% to 12% of all cases of blindness.
Glaucoma is the second leading cause of blindness in the world, according to the World Health Organization.
Is There a Cure For Glaucoma?
To date there is no cure for glaucoma. The best any treatment can do is to halt (or slow) the progression of this disease. The closer the IOP to 8mmHg, the better (below that and the eye can lose vision from the pressure being too low). Studies have shown that for most glaucoma patients an IOP of less than 15mmHg can be protective (a goal often achieved with Canaloplasty). Some forms of glaucoma (such as advanced, low tension, or normal tension glaucoma) require IOPs of less than 12mmHg in order to avoid loss of vision. Only your eye surgeon can determine what your eye’s goal should be.
Read more: http://david-richardson-md.com/glaucoma-treatments/guidelines/#ixzz3IZlkoIbp
Source: http://www.glaucoma.org/glaucoma/glaucoma-facts-and-stats.php
Who’s At Higher Risk?
Factors that increase the glaucoma risk include:
• Age (Individuals over 40)
• Race (Hispanic & African American)
• Family history of glaucoma
• Diabetes
• Eye Trauma
• Long-term use of steroid medications
• Nearsightedness
• Elevated fluid pressure within the eye
Source: http://www.thevisioncouncil.org/content/glaucoma
How is it detected? Screening - IOP - Optic nerve exam - Visual fields - Optic nerve scans
How is it treated? - Drops and pills - Laser - Surgery
- Minimally invasive/Non Penetrating
Argon and Selective Laser Trabeculoplasty (ALT & SLT)
Laser trabeculoplasty uses wavelengths of light focused on the trabecular meshwork (drainage grate inside the eye). For reasons that are not entirely understood, this allows fluid to more easily leave the eye. IOP reductions are modest (usually around 10-15%, or 1-3mmHg) but the procedure is painless, fast, and relatively safe. As such, it can be offered to almost anyone with open angle glaucoma at any stage in the disease. Many doctors will even offer it as “first line” therapy instead of drops. Unfortunately, the effect does not last. After a few years another treatment is generally needed to lower the IOP.Source: http://david-richardson-md.com/glaucoma-treatments/surgeries-procedures/#ixzz3IXaCkOtB
Trabeculectomy
If the eye pressure cannot be controlled with drops, laser, or other surgeries, then a “penetrating surgery”, called trabeculectomy is done. The oldest of modern glaucoma surgeries, trabeculectomy rapidly decreases intraocular pressure by punching a hole in the eye . A flap is left in place in order to control the amount of fluid that percolates under the thin surface layer of tissue (called the “bleb”).
Due to the invasive nature of the procedure, there is the danger of severe bleeding, bleb failure due to sudden decompression post operatively as well as formation of scar tissue. Moreover, trabeculectomy places the eye at increased lifetime risk for infection.
Source: http://david-richardson-md.com/glaucoma-treatments/surgeries-procedures/#ixzz3IXtp6gEF
Glaucoma Drainage Devices, “Tubes” or Stents (aka Setons)
An alternative to trabeculectomy are the glaucoma drainage devices (or “GDDs”), examples of which are the molteno tube and baerveldt shunt. GDDs are made of a light silicone biomaterial. This surgery involves placing a silicon tube in the eye which allows fluid to flow just underneath the surface of the eye along a plate that is sewn onto the eye wall (sclera). The device acts like a garden hose that continuously drains excess fluid out. Generally, this surgery can achieve IOPs in the mid-teens. However the rapid egress of fluid also poses a risk of a condition called hypotony (dangerously low IOP) which can lead to loss of vision. Newer models like the Ahmed shunt possess a valve which provides better control of the drain’s flow rate. However, as with all body implants, there are the risks associated with movement of the implant, infection, as well as scarring that could result in double vision.
Source: http://david-richardson-md.com/glaucoma-treatments/surgeries-procedures/#ixzz3IY1sMaEh
Glaucoma Drainage Devices, “Tubes” or Stents (aka Setons)
An alternative to trabeculectomy are the glaucoma drainage devices (or “GDDs”), examples of which are the molteno tube and baerveldt shunt. GDDs are made of a light silicone biomaterial. This surgery involves placing a silicon tube in the eye which allows fluid to flow just underneath the surface of the eye along a plate that is sewn onto the eye wall (sclera). The device acts like a garden hose that continuously drains excess fluid out. Generally, this surgery can achieve IOPs in the mid-teens. However the rapid egress of fluid also poses a risk of a condition called hypotony (dangerously low IOP) which can lead to loss of vision. Newer models like the Ahmed shunt possess a valve which provides better control of the drain’s flow rate. However, as with all body implants, there are the risks associated with movement of the implant, infection, as well as scarring that could result in double vision.
Source: http://david-richardson-md.com/glaucoma-treatments/surgeries-procedures/#ixzz3IY1sMaEh
Trabectome
This procedure uses a small instrument that opens a section of the trabecular meshwork (the small filter inside the eye that can get “clogged” resulting in high IOP). Once the meshwork is open the fluid in the eye should be able to get to the “collector channels” thereby reducing the IOP. In general, this procedure (when combined with cataract surgery) can lower the IOP into the high teens. Often there is bleeding inside of the eye that can blur vision after Trabectome but it generally resolves in a week or two.
The major downside of this surgery is that once it is done other glaucoma surgeries such as Canaloplasty and placement of an iStent cannot be done. In other words, this procedure “closes doors” on the ability to use other promising glaucoma treatments.Source: http://david-richardson-md.com/glaucoma-treatments/surgeries-procedures/#ixzz3IXv16cU8
EndoCycloPhotocoagulation (ECP)
This procedure uses a small laser probe to heat up and destroy the ciliary body (the tissue that produces fluid in the eye). As with Trabectome, the IOP after ECP is generally in the upper teens. Although a fast procedure, it does result in significant inflammation after surgery which can be both uncomfortable for the patient as well as temporarily blurring the vision.
Source: ://david-richardson-md.com/glaucoma-treatments/surgeries-procedures/#ixzz3IXvBRHga
Glaukos iStent
Recently FDA approved, this snorkel-shaped device can be implanted into the eye’s drainage canal with seemingly miminal risk or additional time. The downside is that it only lowers the IOP by a couple of points so the effect is limited. Multiple stents can be placed (with additive effect) outside of the United States. In the USA, however, only one stent can be placed in the eye and only at the time of cataract surgery. Additionally, a major downside of this surgery is that once it is done other glaucoma surgeries such as Canaloplasty cannot be done. In other words, this procedure “closes a door” on the ability to use a significantly more effective procedure if needed in the future.
Source: http://david-richardson-md.com/glaucoma-treatments/surgeries-procedures/#ixzz3IXvF5FVy
What Is Canaloplasty?
Canaloplasty is an advanced minimally invasive glaucoma treatment. It is a “non-penetrating” glaucoma surgery which means it does not require creation of a hole in the eye (fistula) nor does it result in a “bleb” (blister) as required with the more traditional glaucoma surgery called trabeculectomy (“trab” for short).
Source: http://david-richardson-md.com/canaloplasty-treatment-for-glaucoma/canaloplasty-for-glaucoma/#ixzz3IZOTelyB
What Is Canaloplasty?
Canaloplasty is an advanced minimally invasive glaucoma treatment. It is a “non-penetrating” glaucoma surgery which means it does not require creation of a hole in the eye (fistula) nor does it result in a “bleb” (blister) as required with the more traditional glaucoma surgery called trabeculectomy (“trab” for short).
Source: http://david-richardson-md.com/canaloplasty-treatment-for-glaucoma/canaloplasty-for-glaucoma/#ixzz3IZOTelyB
How is Canaloplasty Performed?
Canaloplasty uses a micro-catheter to open the eye’s natural drainage system (“Schlemm’s canal”). This canal is then opened using a sterile, gel-like material (“viscoelastic”). The iTrack® micro-catheter is then removed while a suture is threaded through Schlemm’s canal. The suture is then tied down resulting in tension on the the inner wall of the canal – just as you might pull on the strings of a “hoodie” to close the hood over your face. The suture placed in the eye’s drainage canal can keep the canal stretched open for years. Once this canal is opened, the eye’s fluid can exit through a more natural process allowing the pressure in the eye to drop to a more normal level.Source: http://david-richardson-md.com/canaloplasty-treatment-for-glaucoma/canaloplasty-for-glaucoma/#ixzz3IZOe1LrM
Benefits of Canaloplasty?
• It uses the eye’s natural drainage system
• It is a “non-penetrating” procedure that does not create a permanent fistula in the wall of the eye
• It does not require a bleb (a blister-like fluid collection)
• Provides long-term reduction in IOP (see three year results below)
• Reduces the need for medications to keep the IOP controlled
• Is a good option for those patients who are not yet ready for more trabeculectomy or tube shunts
• Is safer than traditional glaucoma surgeries (Canaloplasty vs Trabeculectomy)Source: http://david-richardson-md.com/canaloplasty-treatment-for-glaucoma/canaloplasty-for-glaucoma/#ixzz3IZOiIntn
Benefits of Canaloplasty?
• It uses the eye’s natural drainage system
• It is a “non-penetrating” procedure that does not create a permanent fistula in the wall of the eye
• It does not require a bleb (a blister-like fluid collection)
• Provides long-term reduction in IOP (see three year results below)
• Reduces the need for medications to keep the IOP controlled
• Is a good option for those patients who are not yet ready for more trabeculectomy or tube shunts
• Is safer than traditional glaucoma surgeries (Canaloplasty vs Trabeculectomy)Source: http://david-richardson-md.com/canaloplasty-treatment-for-glaucoma/canaloplasty-for-glaucoma/#ixzz3IZOiIntn
Canaloplasty is safe.
Studies which compared the results of Canaloplasty vs. trabeculectomy (the traditional glaucoma surgical treatment) showed that Canaloplasty patients experienced fewer side effects and complications compared to those who had trabeculectomy. And patients who had Canaloplasty had better vision than those patients who had trabeculectomy. For those who are candidates for Canaloplasty, it offers greater safety over trabeculectomy with similar benefits.
Source: http://david-richardson-md.com/canaloplasty-treatment-for-glaucoma/canaloplasty-for-glaucoma/#ixzz3IY7wb2bV
Canaloplasty is effective.
Canaloplasty showed very impressive results in the published 3 Year Clinical Study. Below are just some of the highlights.
The number of medications required to keep the IOP under control was reduced by 53% … this sustained reduction in drops used means that the cost of canaloplasty could easily be paid just with the cost savings from using fewer medications to control IOP.
The reduction in intraocular pressure (IOP) after canaloplasty was 34% – this was the lowest average IOP!
The IOP in those patients who underwent Phacocanaloplasty™ was reduced by almost half (42%)!
88% of patients achieved IOP control without drops three years after canaloplasty!
Source: http://david-richardson-md.com/canaloplasty-treatment-for-glaucoma/canaloplasty-for-glaucoma/#ixzz3IY804GV0
Benefits of Canaloplasty?
• It uses the eye’s natural drainage system
• It is a “non-penetrating” procedure that does not create a permanent fistula in the wall of the eye
• It does not require a bleb (a blister-like fluid collection)
• Provides long-term reduction in IOP (see three year results below)
• Reduces the need for medications to keep the IOP controlled
• Is a good option for those patients who are not yet ready for more trabeculectomy or tube shunts
• Is safer than traditional glaucoma surgeries (Canaloplasty vs Trabeculectomy)Source: http://david-richardson-md.com/canaloplasty-treatment-for-glaucoma/canaloplasty-for-glaucoma/#ixzz3IZOiIntn
Thank you
San Marino Eye Supports National Diabetes Awareness Month